Health
ErbB inhibitor lapatinib exhibits potent anti-SARS-CoV-2 activity – News-Medical.Net
A team of scientists from the USA and Belgium has recently revealed that the ErbB family of receptor tyrosine kinases play a vital role in regulating severe acute…
A team of scientists from the USA and Belgium has recently revealed that the ErbB family of receptor tyrosine kinases play a vital role in regulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lifecycle in host cells and that inhibition of these receptors can protect against SARS-CoV-2-induced acute and chronic lung injuries and inflammation. The study is currently available on the bioRxiv* preprint server.
Background
Since the beginning of the coronavirus disease (COVID-19) pandemic,…
-
General19 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General21 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery
-
Business23 hours agoWhat $10,000 invested in the iShares S&P 500 IVV ETF could be in 10 years
-
Business21 hours agoTop brokers name 3 ASX shares to buy next week 12 October 2025